IP Library Assignment 044331/0555
Patent Assignment
Reel/Frame 044331/0555

Assignment of Assignor's Interest

Recorded: 2017-12-07 Pages: 5
Assignors
LOIBNER, HANS
Executed: 2015-02-23
SCHUSTER, MANFRED
Executed: 2015-02-12
JANZEK-HAWLAT, EVELYNE
Executed: 2015-02-23
WIEDERKUM, SUSANNE
Executed: 2015-02-12
PEBALL, BERNHARD
Executed: 2015-02-12
STRANNER, STEFAN
Executed: 2015-02-12
MUTSCHLECHNER, OLIVER
Executed: 2015-02-12
GROISS, FRANZ
Executed: 2015-02-23
LADENSTEIN, RUTH
Executed: 2015-02-23
LODE, HOLGER
Executed: 2015-02-23
Assignee
APEIRON BIOLOGICS AG
CAMPUS-VIENNA-BIOCENTER 5, VIENNA, 1030, AUSTRIA
Covered Property (1)
Method for Treating a GD2 Positive Cancer
Application: 15/700,538 →
Publication: US 2018/0134801
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
License Dec 7, 2017
From: APEIRON BIOLOGICS AG
To: EUSA PHARMA (UK) LIMITED
Reel/Frame 044801/0254 →
Change of Name Dec 10, 2024
From: APEIRON BIOLOGICS AG
To: APEIRON BIOLOGICS GMBH
Reel/Frame 069584/0365 →
Security Interest Dec 23, 2024
From: APEIRON BIOLOGICS GMBH
To: CITIBANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 069669/0908 →